---
title: "福泰制藥 (VRTX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/VRTX.US/norm.md"
symbol: "VRTX.US"
name: "福泰制藥"
parent: "https://longbridge.com/zh-HK/quote/VRTX.US.md"
datetime: "2026-06-10T08:31:32.212Z"
locales:
  - [en](https://longbridge.com/en/quote/VRTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRTX.US/norm.md)
---

# 福泰制藥 (VRTX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 4.02 | 4.65 | 4.20 | 3.99 | 2.49 |
| ROE | 21.70% | 26.48% | 25.11% | 24.54% | 15.71% |
| 營業收入 | 2.99B | 3.19B | 3.08B | 2.96B | 2.77B |
| 凈利潤 | 1.03B | 1.19B | 1.08B | 1.03B | 646.30M |
| 營業利潤 | 1.14B | 1.26B | 1.24B | 1.15B | 1.03B |
| 毛利率 | 54.66% | 54.87% | 54.74% | 53.25% | 51.53% |
| 凈利率 | 34.53% | 37.34% | 35.20% | 34.84% | 23.33% |
| 利潤含金量 | 79.74% | 253.67% | 99.79% | 107.56% | 125.91% |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 26.48B | 25.64B | 24.86B | 24.04B | 22.88B |
| 權益乘數 | 1.37 | 1.37 | 1.44 | 1.40 | 1.39 |
| 每股凈資產 | 76.18 | 73.49 | 68.20 | 67.01 | 64.20 |
| 資產周轉率 | 0.4950 | 0.4982 | 0.4978 | 0.5171 | 0.4744 |
| 現金及短投 | 7.25B | 6.61B | 6.29B | 6.38B | 6.20B |
| 存貨與應收 | 1.77B | 1.69B | 1.63B | 1.50B | 1.36B |
| 長期投資 | 3.29B | 3.08B | 3.02B | 2.65B | 2.63B |
| 凈債務 | -11.01B | -10.28B | -10.18B | -10.50B | -9.71B |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | 1.43B | 498.00M | 1.24B | 1.07B | 818.90M |
| 投資現金流 | -431.90M | -288.10M | -117.00M | -484.50M | -55.80M |
| 融資現金流 | -538.80M | -77.20M | -1.15B | -349.20M | -680.40M |
| 自由現金流 | 1.01B | -153.74M | 1.02B | 912.38M | 802.04M |
| 現金流充裕率 | 1070.54% | 330.24% | 1202.91% | 730.00% | 2012.04% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | -133.40M | -149.40M | -101.80M | -145.70M | -40.70M |